FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $47,938 | -93.4% | 10,071 | -85.9% | 0.03% | -93.1% |
| Q4 2022 | $721,647 | -55.8% | 71,521 | -1.7% | 0.48% | -52.4% |
| Q3 2022 | $1,631,000 | -4.3% | 72,766 | +5.8% | 1.01% | -3.4% |
| Q2 2022 | $1,705,000 | -23.9% | 68,793 | +19.0% | 1.04% | -13.4% |
| Q1 2022 | $2,241,000 | -21.2% | 57,808 | +18.9% | 1.20% | -20.5% |
| Q4 2021 | $2,844,000 | -1.8% | 48,603 | -0.5% | 1.52% | +13.6% |
| Q3 2021 | $2,895,000 | -32.9% | 48,838 | -1.7% | 1.33% | -38.2% |
| Q2 2021 | $4,312,000 | +11.9% | 49,685 | +6.3% | 2.16% | -2.1% |
| Q1 2021 | $3,855,000 | -2.5% | 46,755 | +7.6% | 2.21% | -19.7% |
| Q4 2020 | $3,953,000 | +132.4% | 43,468 | +13.6% | 2.75% | +114.5% |
| Q3 2020 | $1,701,000 | – | 38,263 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |